Literature DB >> 20472032

Recommendations for rotavirus vaccination: A worldwide perspective.

Carlos Rodrigo1, Nuran Salman, Vladimir Tatochenko, Zsofia Mészner, Carlo Giaquinto.   

Abstract

Official guidelines are crucial for new vaccines to be accepted by physicians and policy makers, and for reimbursement decisions, particularly for vaccines against diseases with an under-appreciated burden, such as rotavirus gastroenteritis (RVGE). Evidence-based guidelines, which take into account the best available data, ensure that new vaccine introductions achieve the greatest sustainable impact. For rotavirus vaccination, guidelines are specific to the locality for which they are developed, reflecting, for example, potential differences in disease burden, prevalence of co-infections (e.g. human immunodeficiency virus) and existing vaccination schedules. By adapting existing evidence-based guidelines, local strategies can be devised to optimise protection against RVGE in different settings. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20472032     DOI: 10.1016/j.vaccine.2010.04.108

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Knowledge and attitudes towards rotavirus diarrhea and the vaccine amongst healthcare providers in Yogyakarta Indonesia.

Authors:  Holly Seale; Mei Neni Sitaresmi; Jarir Atthobari; Anita E Heywood; Rajneesh Kaur; Raina C MacIntyre; Yati Soenarto; Retna Siwi Padmawati
Journal:  BMC Health Serv Res       Date:  2015-11-30       Impact factor: 2.655

2.  Variation in rotavirus vaccine coverage by sub-counties in Kenya.

Authors:  Ernest Apondi Wandera; Shah Mohammad; John Odhiambo Ouko; James Yatitch; Koki Taniguchi; Yoshio Ichinose
Journal:  Trop Med Health       Date:  2017-04-24

Review 3.  Rotavirus in Calves and Its Zoonotic Importance.

Authors:  Umer Seid Geletu; Munera Ahmednur Usmael; Fufa Dawo Bari
Journal:  Vet Med Int       Date:  2021-04-21

4.  Balancing safety, efficacy and cost: Improving rotavirus vaccine adoption in low- and middle-income countries.

Authors:  Anant Bhan; Shane K Green
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

5.  Therapeutics Insight with Inclusive Immunopharmacology Explication of Human Rotavirus A for the Treatment of Diarrhea.

Authors:  Mohammad Uzzal Hossain; Abu Hashem; Chaman Ara Keya; Md Salimullah
Journal:  Front Pharmacol       Date:  2016-06-23       Impact factor: 5.810

6.  Effectiveness of Rotarix ® vaccine in Africa in the first decade of progressive introduction, 2009-2019:  systematic review and meta-analysis.

Authors:  Nickson Murunga; Grieven P Otieno; Marta Maia; Charles N Agoti
Journal:  Wellcome Open Res       Date:  2020-09-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.